Excessive alcohol consumption is one of the main causes of death and disability worldwide. Alcohol consumption is a heritable complex trait. Here we conducted a meta-analysis of genome-wide association studies of alcohol consumption (g d −1
) from the UK Biobank, the Alcohol Genome-Wide Consortium and the Cohorts for Heart and Aging Research in Genomic Epidemiology Plus consortia, collecting data from 480,842 people of European descent to decipher the genetic architecture of alcohol intake. We identified 46 new common loci and investigated their potential functional importance using magnetic resonance imaging data and gene expression studies. We identify genetic pathways associated with alcohol consumption and suggest genetic mechanisms that are shared with neuropsychiatric disorders such as schizophrenia.
A full list of affiliations appears at the end of the paper.
E
xcessive alcohol consumption is a major public health problem that is responsible for 2.2% and 6.8% of age-standardized deaths of women and men, respectively 1 . Most genetic studies of alcohol consumption focus on alcohol dependency, although the population burden of alcohol-related disease mainly reflects a broader range of behaviours associated with alcohol consumption 2 . Small reductions in alcohol consumption could have major public health benefits; even moderate decreases in alcohol consumption per day may have a substantial effect on rates of mortality 3 . Alcohol consumption is a heritable complex trait 4 , but genetic studies to date have robustly identified only a small number of associated genetic variants [5] [6] [7] [8] . These include variants in the aldehyde dehydrogenase (ADH) gene family-a group of enzymes that significantly associated variant-rs1991556 (P = 4.5 × 10
)-is an intronic variant in MAPT, which encodes the microtubule-associated protein tau, that was found through PhenoScanner to be associated with not only dementia 15 and Parkinson's disease 16, 17 , but also with neuroticism, schizophrenia 18 and other traits [19] [20] [21] (see Methods; Table 6 ). The second most significantly associated variant, rs1004787 (P = 6.7 × 10 −17
), is located near SIX3, which encodes a member of the sine oculis homeobox transcription factor family involved in the development of the eyes 22 . The third most significantly associated SNP, rs13107325 (P = 1.3 × 10
), is a missense SNP in SLC39A8 (NCBI Gene 64116)-which encodes a member of the SLC39 family of metal-ion transporters-that has been associated with schizophrenia 23 as well as inflammatory bowel disease, cardiovascular and metabolic phenotypes [24] [25] [26] [27] in previous GWAS (Fig. 2, Supplementary Table 6 ).
Another of our most-significant variants-an intronic SNP rs7121986 (P = 6.2 × 10 −14 ) in DRD2 (NCBI Gene 1813)-is located in the gene that encodes the dopamine receptor D2 that has been associated with cocaine addiction, neuroticism and schizophrenia 18 . We also found significant associations with SNP rs988748 (P = 4.4 × 10 −9
) in the BDNF gene (NCBI Gene 627), which encodes a member of the nerve growth factor family of proteins, and rs7517344, which is located near ELAVL4 (NCBI Gene 1996; P = 2.0 × 10 −10 ), the product of which is involved in the regulation of BDNF 28 . Previous studies have suggested that a variant of BDNF is associated with alcohol consumption and that alcohol consumption modulates the expression of BDNF 29 .
We also found that alcohol consumption is associated with SNP rs838145 (P = 3.2 × 10 −15
), which has been associated with macronutrient intake in a previous GWAS 30 . This variant is nearest to IZUMO (NCBI Gene 284359) in a locus of around 50 kb that spans a number of genes including FGF21 (NCBI Gene 26291), the gene product of which, FGF21, is a liver hormone that is involved in the regulation of alcohol preference, glucose and lipid metabolism 31 . We previously reported a significant association of alcohol intake with SNP rs11940694 in KLB (NCBI Gene 152831)-an obligate receptor of FGF21 in the brain 5 -and we strongly replicated that finding here (P = 3.3 × 10
−68
). As well as variants in KLB and in the alcohol dehydrogenase locus (smallest P = 1.2 × 10 −125 ), we found support (P = 1 × 10
) for the association of common variants in three other loci related to alcohol intake that were previously reported in GWAS (Supplementary  Table 7 ), including SNP rs6943555 in AUTS2 (NCBI Gene 26053; P = 2.9 × 10 −6 ). We also found that a new SNP related to alcohol intake, rs1421085 in FTO (NCBI Gene 79068), is in high LD (r 2 = 0.92) with a variant that has been previously reported to have a genome-wide significant association with alcohol dependence 32 . catalyse the oxidation of aldehydes 9 -including a cluster of genes on chromosome 4q23 (ADH1B, ADH1C, ADH5, ADH6 and ADH7) 6 . Here we report a genome-wide association studies (GWAS) meta-analysis of alcohol intake (log-transformed alcohol intake (g d −1 )) among individuals of European ancestry drawn from the UK Biobank (UKB) 10 , the Alcohol Genome-Wide Consortium (AlcGen) and the Cohorts for Heart and Aging Research in Genomic Epidemiology Plus (CHARGE+) consortia. In brief, UKB is a prospective cohort study comprising approximately 500,000 individuals recruited between the ages of 40 yr and 69 yr. Participants were asked to report their average weekly and monthly alcohol consumption through a self-completed touchscreen questionnaire 10 . On the basis of these reports, we calculated the alcohol intake (g d
; see Methods). Participants were genotyped using a customized array with imputation from the Haplotype Reference Consortium (HRC) panel 11 , yielding approximately 7 million common single nucleotide polymorphisms (SNPs) with a minor allele frequency (MAF) of ≥1% and imputation quality INFO score of ≥0.1. After quality control (QC) and exclusions (see Methods), we performed a GWAS of alcohol consumption using data from 404,731 participants of European descent from the UKB under an additive genetic model (see Methods; Supplementary Table 1) . We found that genomic inflation in the UKB analysis was λ GC = 1.45, but we did not adjust for inflation because the linkage disequilibrium score regression (LDSR) intercept was 1.05, indicating that the genomic inflation was due to polygenicity rather than to population stratification 12 .
The estimated SNP-wide heritability of alcohol consumption in the data from the UKB was 0.09.
We also performed a GWAS on the basis of 25 independent studies from the AlcGen and CHARGE+ consortia, including 76,111 participants of European descent for whom alcohol consumption
) could be calculated (Supplementary Table 2 ). Various arrays were used for genotyping, and imputation was performed using either the 1000 Genomes reference panel or the HRC platforms (Supplementary Table 3 ). After QC, we applied genomic control at the individual-study level and obtained summary results for approximately 7 million SNPs with an imputation quality score of ≥0.3 (see Methods).
We combined the UKB, AlcGen and CHARGE+ results using a fixed-effects inverse-variance-weighted approach for a total of 480,842 individuals 13 . To maximize power, we performed a single-stage analysis to test common SNPs with a MAF of ≥1%. We set a stringent P-value threshold of P < 5 × 10 −9 to denote significance in the combined meta-analysis 14 and required signals to be at P < 5 × 10 −7 in UKB-with the same direction of effect in UKB and AlcGen plus CHARGE+-to minimize false-positive findings. We excluded SNPs within 500 kb of variants reported as genome-wide significant in previous GWAS of alcohol consumption 5, 6 , identified new loci by requiring SNPs to be independent of each other (linkage disequilibrium (LD; r 2 < 0.1) and selected the sentinel SNP within each locus according to lowest P value (see Methods).
We then tested for correlations of alcohol-associated SNPs with imaging phenotypes of brain, heart and liver (as measured by MRI), and gene expression. We tested the sentinel SNPs for association with other traits and diseases and used Drosophila mutant models to investigate functional effects of mutations on behaviours induced by ethanol.
Results
Our meta-analysis identified 46 new loci associated with alcohol consumption (log-transformed alcohol intake (g d Table 1 ). All inferential statistics for the new loci are reported in Table 1, whereas  heterogeneity metrics are presented in Supplementary Table 4 . We also discovered a further eight variants in the combined analysis at nominal genome-wide significance (P < 1 × 10
) that may be associated with alcohol intake (Supplementary Table 5 ). The most ) among 480,842 individuals across UKB, AlcGen and CHARGE+, excluding known variants. The P value was computed using inverse-variance fixed-effects models. The y axis shows the -log 10 P values, and the x axis shows their chromosomal positions. The horizontal blue line represents the threshold of P = 5 × 10 Conditional analysis using Genome-wide Complex Trait Analysis (GCTA) software did not reveal any independent secondary signals related to alcohol consumption. Among approximately 14,000 individuals in the independent Airwave cohort 33 (see Methods), 7% of the variance in alcohol consumption was explained by the new and known common variants. Using weights from our analysis, we constructed an unbiased weighted genetic risk score (GRS) in the Airwave cohort (see Methods) and found a strong association of the new and known variants with levels of alcohol consumption (P = 2.75 × 10 −14 ), with a mean difference in sex-adjusted alcohol intake of 2.6 g d −1 when comparing the top and the bottom quintile of the GRS (Supplementary Table 8 ).
Associations with MRI phenotypes. We functionally characterized new variants by carrying out single-SNP analyses of the imaging phenotypes in the UKB (see Methods), focusing on brain (n = 9,702), heart (n = 10,706) and liver (n = 8,479).
Using Bonferroni correction (corrected P = 6.6 × 10
, corresponding to 0.05/46 SNPs × 164 imaging phenotypes), we found significant positive associations between SNP rs13107325 in SLC39A8 and the volumes of multiple brain regions; all inferential statistics for these associations are reported in Supplementary  Table 9 . The strongest associations were found for the putamen (left: P = 2.5 × 10 ; right: P = 9.6 × 10
) and the cerebellum (strongest association for left I-IV volume, P = 1.2 × 10 −9
; Supplementary Table 9 ). Similar findings were recently reported in a GWAS using brain imaging in UKB 34 . We also showed a significant association between rs1991556 and the parahippocampal gyrus (P = 1.2 × 10
−6
). We then tested these brain regions for association with alcohol consumption and found a significant effect for the left (t 8,601 = −3.7, effect size (β) ± s.e. = −0.0019 ± 0.0005, P = 2.0 × 10 ) putamen. Finally, we used data from n = 8,610 individuals and performed a mediation analysis using a standard three-variable path model, bootstrapping 10,000 times, to calculate the significance of the mediation effect of putamen volume for genetic influences on alcohol consumption (see Methods). We found evidence that the effect of SNP rs13107325 in SLC39A8 on alcohol intake is partially mediated by its association with the volume of the left (t 8,601 = −3.03, β ± s.e. = −0.27 ± 0.09, P = 1.9 × 10 −3 ) and right (t 8,601 = −2.82, β ± s.e. = −0.27 ± 0.09, P = 1.7 × 10 Table 10 ). To exclude the possibility of an inverse causal pathway, we performed additional analyses in UKB non-drinkers (n = 589). With 10,000 random permutations, associations of rs13107325 with both left and right putamen remained significant (left putamen: t 541 = 1.06, P = 0.02; right putamen: t 541 = 0.38, P = 0.04), indicating that the association between rs13107325 and putamen regions is not mediated by alcohol intake.
We did not find any significant associations between the new SNPs and either cardiac (left ventricular mass or end diastolic volume or right ventricular end diastolic volume; Supplementary Table 11) or liver fat measurements from MRI analysis (Supplementary  Table 12 ) after adjustment for multiple testing.
Effects of SNPs on gene expression.
We carried out expression quantitative trait loci (eQTL) analyses using the Genotype-Tissue Expression (GTEx) and the UK Brain Expression Consortium (UKBEC) datasets. We found that 34 of the 53 new and known SNPs associated with alcohol consumption have a significant effect on gene expression in at least one tissue type, including 33 SNPs that affect gene expression in the brain (Supplementary Tables 13 and 14 Results are ordered by P values of the combined analysis. CP, chromosome and position (build hg19/37); EA, effect allele of the discovered SNP; EAF, frequency of the effect allele. ; Supplementary Fig. 2) . Similarly, the A allele at SNP rs2071305 within MYBPC3 (NCBI Gene 4607) affects the expression of several genes and is most significantly associated with increased expression of C1QTNF4 (NCBI Gene 114900) across several tissues (P = 1.9 × 10 −25 to P = 8.4 × 10
Table 1 | Association results of 46 new alcohol variants identified through the meta-analysis of UKB and AlcGen and CHARGE+ (continued)
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). Several of these eQTLs were found to affect expression of genes known to be involved in reward and addiction. SNP rs1053651 in the TCAP-PNMT-STARD3 gene cluster affects expression of PPP1R1B (also known as DARPP-32; NCBI Gene 84152), which encodes a protein that mediates the effects of dopamine in the mesolimbic reward pathway 35 . Other known addiction-related genes include ANKK1 (NCBI Gene 255239) and DRD2 (expression affected by SNP rs7121986), genes implicated in alcohol and nicotine dependence 36, 37 , CRHR1 (NCBI Gene 1394; affected by SNP rs1991556), which is involved in stress-mediated alcohol dependence 38, 39 , and PPM1G (SNP rs1260326; NCBI Gene 5496), epigenetic modification of which was previously reported to be associated with alcohol abuse 40 . Over-representation enrichment analyses on the basis of functional annotations and disease-related terms indicated that genes of which the expression is affected by the identified eQTLs are most significantly enriched for terms related to abdominal (n = 91) and other malignant cancers, motor function (n = 5) and cellular homeostasis (n = 22; Supplementary Fig. 4 ). We performed a genebased analysis and repeated the over-representation enrichment analysis, adding the new set of identified genes (Supplementary Table 15 ). The results were similar, supporting an enrichment for abdominal (n = 100) and other cancers, as well as motor function (n = 5) and cellular homeostasis (n = 24; Supplementary Fig. 5 ).
Other traits and diseases. Using LDSR 12 , we assessed genetic correlations between alcohol consumption and 235 complex traits and The left putamen is indicated in green and the right putamen is indicated in red. We use a for the relationship between rs13107325 and putamen, b for the relationship between putamen and alcohol consumption, c for the relationship between rs13107325 and alcohol consumption, c′ for the relationship between rs13107325 and alcohol consumption after excluding the effect of putamen, and ab as the mediation effect. The significance tests are based on the bootstrapping method (10,000 times). z-statistics and the corresponding P values are provided in parentheses. The brain icon was created using Mango software v4.1 (http://ric.uthscsa.edu/mango/).
diseases from publicly available GWAS summary statistics (see Methods). All results-including their statistics (that is, r g, s.e., z value and P value)-are included in Supplementary Table 16 . The strongest positive genetic correlations on the basis of false-discovery rate (FDR)-adjusted values of P < 0.02 were found for smoking (r g = 0.42, P = 1.0 × 10
) and levels of high-density lipoprotein (HDL) cholesterol (r g = 0.26, P = 5.1 × 10
−13
). We also found negative correlations for sleep duration (r g = −0.14, P = 3.8 × 10 ) and fasting insulin levels (r g = −0.25, P = 4.5 × 10
−6
). A significant genetic correlation was also found with schizophrenia (r g = 0.07, P = 3.9 × 10 ; Supplementary Table  16 ). Over-representation enrichment analysis using WebGestalt 41 (http://www.webgestalt.org) showed that our list of new and known variants is significantly enriched for several diseases and traits, including developmental disorder in children (P = 7.3 × 10 ; Supplementary Fig. 6 ). Mendelian randomization analysis (see Methods) was performed to assess a potential causal effect of alcohol on schizophrenia risk using the inverse-variance weighted approach, but this analysis did not show significant results (P = 0.089), showing large heterogeneity of the estimates of the tested variants.
Functional studies in Drosophila. On the basis of our GWAS and brain imaging findings, we performed further testing on the SNP rs13107325 in SLC39A8 (also known as ZIP8) in Drosophila, making use of conserved mechanisms to modulate behaviours that are induced by ethanol 42, 43 . First, we overexpressed human ZIP8 using a Gal4 driver that included expression in neurons involved in multiple ethanol-induced behaviours 43 .
Flies carrying ics

Gal4
/+ UAShZIP8/+ showed a slight-albeit significant-resistance to sedation induced by ethanol compared with control flies (t 30 = 2.3, Hedge's g = 0.80, 95% confidence interval (CI) = 0.08-1.53, P = 0.026, n = 16 per genotype). Ethanol tolerance, induced by repeated exposures that were separated by recovery for 4 h, was unchanged in these flies (t = 1.0, P = 0.33; Fig. 4a ). Next, we used the same Gal4 driver to knock down the endogenous Drosophila orthologue of hZIP8, dZip71B. This caused the flies to display naive sensitivity to sedation induced by ethanol (t 14 = 3.98, Hedge's g = −1.84, 95% CI = −0.67 to −3.01, P = 0.0014; n = 8 per genotype) and, furthermore, these flies developed greater tolerance to ethanol after repeated exposure (t 14 = 4.80; Hedge's g = 2.29, 95% CI = 1.03-3.55, P = 0.0003; Fig. 4b ). To corroborate this phenotype, we then tested flies that were transheterozygous for two independent transposon insertions in the middle of the dZip71B gene ( Supplementary Fig. 7 ) and found that these dZip71B
Mi/MB flies also displayed naive sensitivity to sedation induced by ethanol (t 14 = 3.23, Hedge's g = −1.54, 95% CI = −0.42 to −2.65, P = 0.006) and increased ethanol-induced tolerance (t 14 = 2.39, Hedge's g = 1.13, 95% CI = 0.07-2.18, P = 0.032) compared with the controls (n = 8 each; Fig. 4c ).
Discussion
Our discovery utilizing data on common variants from more than 480,000 people of European descent extends our knowledge of the genetic architecture of alcohol intake, increasing the number of identified loci to 46. We identified loci involved in neuropsychiatric conditions such as schizophrenia, Parkinson's disease and dementia, as well as BDNF, gene expression of which is affected by alcohol abuse. Our findings illustrate that large-scale studies of genetic associations with alcohol intake in the general population-rather than studies on alcohol dependency alone-can provide further insights into the genetic mechanisms that regulate the consumption of alcohol.
We highlight the role of the highly pleiotropic MAPT and SLC39A8 genes in the genetics of alcohol consumption. MAPT plays an important role in tau-associated dementia 44 and both MAPT and SLC39A8 are implicated in other neuropsychiatric conditions, including neuroticism, schizophrenia and Parkinson's disease [16] [17] [18] . SLC39A8 encodes a member of the SLC39 family of metal-ion transporters. SLC39A8 is glycosylated and found in the plasma membrane and mitochondria, and is involved in the cellular transport of zinc, the modulation of which could affect microglial inflammatory responses 45 . Our gain-of-function and loss-of-function studies in Drosophila indicate a potential causal role of SLC39A8 in alcohol-consumption behaviour, although these results should be interpreted with caution owing to the small sample size in our experiment. Using MRI brain imaging, we demonstrate a significant association between SNP rs13107325 in SLC39A8 and differences in the volume of the putamen, and that these structural differences seem to partially mediate associations between rs13107325 and alcohol consumption. The putamen has been associated with alcohol consumption and the withdrawal syndrome after chronic administration to rodents and non-human primates 46 . On the basis of the mediation analysis, we suggest a plausible causal pathway that links rs13107325 in SLC39A8 with alcohol intake through an effect on putamen volume, but further studies are needed to conclusively demonstrate causal links. Differences in the volume of the putamen have also been associated with both schizophrenia and psychosis 47, 48 and a robust association between SNP rs13107325 in SLC39A8 and schizophrenia was reported in a previous GWAS 23 . We also report SNP rs7121986-which is located near DRD2-as a new variant associated with alcohol intake in GWAS. The gene product of DRD2, D2 dopamine receptor, is a G-protein-coupled receptor expressed on post-synaptic dopaminergic neurons that has long been implicated in alcoholism 49 . We also identify SNP rs988748 in BDNF as a new alcohol intake variant; BDNF expression is differentially affected by alcohol exposure in animal models 50, 51 . DRD2 and BDNF (along with PPP1R1P) are centrally involved in rewardmediating mesocorticolimbic pathways and are both implicated in the development of schizophrenia. For example, there is a robust GWAS association between schizophrenia and SNP rs4938021 in DRD2 (in perfect LD with our new alcohol intake-related variant rs7121986) and DRD2 seems to be pivotal in network analyses of genes involved in schizophrenia 52 . Taken together, our results suggest that there are shared genetic mechanisms between the regulation of alcohol intake and susceptibility to schizophrenia, as well as other neuropsychiatric disorders. Related to this, large prospective epidemiological studies report a threefold risk of schizophrenia in relation to alcohol abuse 53 . We previously reported genome-wide significant associations between alcohol intake and KLB, and identified a liver-brain axis that linked the liver hormone FGF21 with central regulation of alcohol intake, which involved the β-klotho receptor (the gene product of KLB) in the brain 5 . Here we identified a significant variant near FGF21 and strongly replicate the previously reported KLB gene variant, strengthening the genetic evidence for the importance of this pathway in the regulation of alcohol consumption.
The LDSR analysis showed a positive genetic correlation between alcohol consumption, smoking and levels of HDL cholesterol. This confirms previous studies that reported an almost-identical genetic correlation between alcohol consumption and the number of cigarettes smoked per day 54 . Furthermore, the observed genetic correlation with HDL levels is consistent with previous observations of an association between alcohol consumption and HDL 55, 56 , including results of a Mendelian randomization study that suggested a possible causal role linking alcohol intake with increased HDL levels 57 . Moreover, we found an inverse genetic correlation between the duration of sleep and consumption of alcohol-an association that has been previously reported only in a few small epidemiological studies 58 . We also found a significant genetic correlation between schizophrenia and bipolar disorder, a result that is supported by a recently published trans-ethnic meta-analysis of case-control studies on alcohol dependence 59 . We could not test for a genetic association between alcohol and risk of alcohol-related cancers 60 owing to the limited availability of summary data. However, our gene-set enrichment analysis showed a significant enrichment for genes related to abdominal as well as other cancers.
The strengths of our study include its size, detailed attention to the alcohol phenotype, dense coverage of the genome through imputation, and incorporation of brain and other imaging data to explore potential mechanisms. More than 80% of the data came from UKB, which combines high-quality phenotypic data and imputed genome-wide genetic data with strict attention to QC 61 . We adopted a stringent approach to claim new variants, including a conservative P-value threshold, internal replication in UKB and consistent direction of effect with the other studies to minimize the reporting of false-positive signals.
However, because alcohol intake is socioculturally and genetically determined, it is influenced by other lifestyle and environmental factors that may modify or dilute the genetic signal. A key limitation is that assessment of alcohol intake relies on self-reporting, which is prone to errors and biases, including recall bias and systematic under-reporting by heavy drinkers 62, 63 . Furthermore, questionnaires on alcohol intake covered a short duration (for example, a day or week) for a single period, which may not be representative of broader drinking patterns of cohort participants. We harmonized data across cohorts by converting alcohol intake into a common metric of g d , with imputation where necessary in UKB for participants that reported consumption of small amounts of alcohol. Taking this approach, we were able to detect strong genetic associations with alcohol intake that explained 7% of the variance in alcohol consumption in an independent cohort, whereas our GRS analysis indicates that individuals in the lower fifth of the GRS distribution were consuming approximately one third of a standard drink (2.6 g d −1 alcohol) less each day compared with those in the upper fifth.
We should also point out that our eQTL analyses are a first step in the identification of causal genes. Yet, as the most significant eQTLs affect expression of many genes-which are not necessarily the nearest genes-there is a need to further prioritize potential causal genes. Unbiased strategies that leverage information from multiple datasets, including extensive genomic annotations and high-throughput functional screening in a broad range of tissues, will be essential to effectively prioritize genes and uncover underlying causal mechanisms 64 . Establishing confidence in the prioritized genes in such a way is a prerequisite for performing functional follow-up studies in appropriate model systems, as demonstrated by the identification of the causal genes and potential disease mechanisms at the obesity-associated FTO locus 65 . In summary, in this large study of genetic associations with alcohol consumption, we identified common variants in 46 new loci. Several of these variants are located in genes that are expressed in the brain as well as other tissues. Our findings suggest that there may be shared genetic mechanisms that underpin the regulation of alcohol intake and development of neuropsychiatric disorders, including schizophrenia. This may form the basis for a greater understanding of observed associations between alcohol consumption, schizophrenia 66 and other disorders.
Methods
UKB data.
We conducted a GWAS analysis using data from 458,577 UKB participants of European descent who were identified on the basis of a combination of self-reported and genetic data. The details of the selection of participants have been described elsewhere 14 . These participants comprised 408,951 individuals from the UKB, genotyped at 825,927 variants using a custom Affymetrix UKB Axiom Array chip, and a further 49,626 individuals from the UK BiLEVE study-which is a subset of UKB-genotyped at 807,411 variants using a custom Affymetrix UK BiLEVE Axiom Array chip. For our analyses, we used SNPs imputed centrally by UKB using the HRC panel.
Alcohol intake. We calculated alcohol intake as g d −1 on the basis of self-reported levels of alcohol consumption that were provided through a touch-screen questionnaire. The quantity of each type of drink (red wine, white wine, beer or cider, fortified wine or spirits) was multiplied by its standard drink size and reference alcohol content. Drink-specific intake during the reported drinking period (per week for frequent drinkers, defined as: daily or almost daily, once or twice a week, three or four times a week, or per month for occasional drinkers, defined as: one to three times a month or special occasions only) was summed and converted to g d −1 alcohol intake for all participants who provided a complete response to the quantitative drinking questions. The alcohol intake for participants who submitted incomplete responses was imputed by bootstrap resampling from the complete responses, stratified by drinking frequency (occasional or frequent) and sex.
Participants were defined as life-time non-drinkers if they reported 'never' on the question on alcohol drinking frequency (UKB field 1558) and 'no' for the question on former drinker (UKB field 3731); these participants were excluded from further analysis. We considered participants with alcohol consumption of more than 500 g d −1 to be outliers and they were excluded from further analysis. We also excluded participants with missing covariates, leaving data on 404,732 individuals. The log 10 -transformed alcohol and sex-specific residuals were derived from the regression of log 10 -transformed alcohol intake on age, age 2 , genotyping chip and weight.
UKB genetic analysis.
We performed linear mixed modelling with BOLT-LMM software 67 using an additive genetic model to determine associations between measured and imputed SNPs and alcohol consumption (sex-specific residuals of the log 10 -transformed alcohol intake variable). Model building was based on SNPs with MAF > 5%, call rate > 98.5% and Hardy-Weinberg equilibrium P > 1 × 10
. SNPs were imputed using the HRC panel with an imputation quality INFO score of ≥0.1. We estimated the LDSR intercept to assess the degree of genomic inflation beyond polygenicity as well as the genomic inflation factor 68 λ GC .
AlcGen and CHARGE+ consortia. We analysed GWAS data that were available from 25 independent studies (n = 76,111) conducted by the AlcGen and the CHARGE+ consortia. All study participants were of reported European ancestry and data were imputed to either the 1000 Genomes Project or the HRC panel. Alcohol intake in g d −1 was computed and the log 10 -transformed residuals were analysed as described above. Study names, cohort information and general study methods are included in Supplementary Tables 2 and 3. All studies were subject to central QC using easyQC 69 , including filtering for MAFs. Finally, we analysed data on approximately 7.1 million SNPs with MAF > 1% and imputation quality score (Impute (INFO score) or Mach (r 2 )) ≥ 0.3. Genomic control (GC) was applied at the study level. We generated the available GWAS using a fixed-effects inverse-variance weighted meta-analysis and summary estimates were derived for AlcGen and CHARGE+.
One-stage meta-analysis. We performed a one-stage meta-analysis, in which we applied a fixed-effects inverse-variance weighted meta-analysis using METAL 70 to obtain summary results from the UKB and AlcGen plus CHARGE+ GWAS for up to 480,842 participants and around 7.1 million SNPs with MAF ≥ 1% for variants present in both the UKB data and AlcGen and CHARGE+ meta-analysis. We assessed the observed heterogeneity using Cochran's Q and we quantified this using the I 2 metric. We considered a Cochran's Q P < 1 × 10 −4 to be significant. The LDSR intercept (s.e.) in the discovery meta-analysis was 1.05 and no further correction was applied. Quantile-quantile plots of the combined meta-analysis summary results, UKB only, and AlcGen and CHARGE+ only are presented in Supplementary Fig. 8 .
Previously reported SNPs.
We searched the GWAS Catalog (https://www. ebi.ac.uk/gwas/) and identified 17 SNPs associated with alcohol consumption at genome-wide level of significance (P < 5 × 10
−8
). We enhanced the list with reference to a recent GWAS by Clarke et al. 6 that was not covered by the GWAS Catalog at the time of the analysis, reporting 14 additional rare and common SNPs. Together with a SNP in RASGRF2, which has been shown to be associated with alcohol-induced reinforcement 71 , we found 31 previously reported alcoholconsumption-related SNPs.
New loci.
Using the locus definition of SNPs that are within a distance of ±500 kb of each other and SNPs that were in LD (r 2 > 0.1) as calculated using PLINK, we augmented the list of known SNPs with all SNPs present within our data that were not contained within the previously published loci. We further excluded SNPs in the human leukocyte antigen region (chromosome 6, 25-34 Mb) owing to its complex LD structure. Using PLINK, we then performed LD clumping on 4,515 unknown SNPs with P < 1 × 10 −8 using an r 2 > 0.1 and a distance threshold of 500 kb. We further grouped the lead SNPs within 500 kb of each other into the same loci and selected the SNP with smallest P value from the locus as sentinel SNP.
We report a SNP as a new signal of association with alcohol consumption if the following criteria are fulfilled:
1. The sentinel SNP has P < 5 × 10 −9 in the one-stage meta-analysis. 2. The sentinel SNP is strongly associated (P < 5 × 10
) in the UKB GWAS alone. 3. The sentinel SNP has a concordant direction of effect between UKB and AlcGen and CHARGE+ datasets. 4. The sentinel SNP is not located within any of the previously reported loci.
We selected criteria (1)- (3) to minimize false-positive findings, including use of a conservative one-stage P-value threshold that was an order of magnitude more stringent than a genome-wide significance P value (for example, the threshold of P < 5 × 10 −9 has been proposed for whole-genome sequencing-based studies). This approach allowed us to identify 46 sentinel SNPs in total. Regional plots for all 46 sentinel SNPs are presented in Supplementary Fig. 9 .
Conditional analysis. We conducted locus-specific conditional analysis using the GCTA software (https://cnsgenomics.com/software/gcta). For each of the 46 new sentinel SNPs, we obtained conditional analysis results for the SNPs with a MAF of >1% and located within 500 kb of the sentinel SNP after conditioning on the sentinel SNP. The meta-analysis results of the GWAS in the UKB, AlcGen and CHARGE+ were used as input summary statistics and the individual-level genetic data from the UKB were used as the reference sample. Results for a SNP were considered to be conditionally significant if the difference between the conditional P value and the original P value was greater than 1.5-fold (−log 10 [P]/− log 10 [P conditional ] > 1.5) and the conditional P value was smaller than 5 × 10
Gene-based analysis. We performed a gene-based analysis using fastBAT, a method that performs a set-based association analysis using summary-level data from GWAS. We used the UKB dataset as a reference set for the LD calculations 72 . Gene-based associations with P < 5 × 10 −9 were considered to be significant.
Gene expression analyses.
To analyse the impact of genetic variants on the expression of neighbouring genes and identify eQTLs (cis-eQTLs; that is, SNPs associated with differences in local gene expression), we used two publicly available databases-the GTEx database 73 (https://www.gtexportal.org) and the UKBEC dataset 74 (http://www.braineac.org). We searched these databases for significant variant-transcript pairs for genes within 1 Mb of each input SNP.
Using the GTEx database, we tested for cis-eQTL effects in 48 tissues from 620 donors. The data described herein were obtained from the GTEx Portal v.7, and we used FastQTL 75 to map SNPs to gene-level expression data and calculate q values on the basis of β-distribution-adjusted empirical P values 76 . A FDR threshold of P ≤ 0.05 was applied to identify genes with a significant eQTL. The effect sizedefined as the slope of the linear regression-was computed in a normalized space (normalized effect size (NES)) in which magnitude has no direct biological interpretation. Here, NES reflects the effects of our GWAS effect alleles (that are not necessarily the alternative alleles relative to the reference alleles, as reported in the GTEx database). Supplementary Table 13 lists transcript-SNP associations with significant eQTL effects.
Using the UKBEC dataset that comprises 134 brains (http://www.braineac. org/), we searched for cis-eQTLs in 10 brain regions, including the cerebellar cortex (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus; MEDU), occipital cortex (specifically primary visual cortex; OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX) and intralobular white matter (WHMT), as well as across all brain tissues (aveALL). We used MatrixEQTL 77 to generate P values for each expression profile (at either the exon level or gene level) against the respective SNP for the 10 different brain regions and all brain tissues. Supplementary Table 14 lists transcript-SNP associations with a eQTL P < 0.0045 in at least one brain tissue. Subsequent data analysis was performed in R v3.5 (https://www.R-project.org/).
We performed over-representation enrichment analysis using a list of 146 GTEx eQTL genes that were derived from the single-variant analysis and a list of 160 eQTL genes that were derived from both single-variant and gene-based analysis. Ingenuity pathway analysis (QIAGEN) was performed on these lists using ontology annotations from all available databases, except those derived from lowconfidence computational predictions.
MRI data.
We used the most recent release of MRI data on brain, heart and liver from participants of the UKB to investigate genetic associations between the 46 new SNPs and alcohol consumption.
Brain imaging. Brain MRI acquisition and preprocessing. We used the T1 data from the UKB to elucidate volumetric brain structures, including the cortical and the sub-cortical areas. The T1 data were acquired and preprocessed centrally by the UKB. The brain regions were defined by combining the Harvard-Oxford cortical and subcortical atlases 78 (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases) and the Diedrichsen cerebellar atlas 79 (http://www.diedrichsenlab.org/imaging/ propatlas.htm). FAST (FMRIB's Automated Segmentation Tool) 80 was then used to estimate the grey-matter partial volume within each brain region. Subcortical region volumes were also modelled using FIRST (FMRIB's Integrated Registration and Segmentation Tool). More details about the MRI scanning protocol and preprocessing are provided in the UKB documentation (https://biobank.ctsu.ox.ac. uk/crystal/crystal/docs/brain_mri.pdf).
Association analyses. We performed association analyses on n = 9,702 individuals between all new SNPs and the grey-matter volume of brain regions using Pearson correlation, adjusting for age, age 2 , sex, age × sex, age 2 × sex and head size. Brainvolume features, log-transformed alcohol intake data (g d −1 ) and the confounding factors were initially transformed using a rank-based inverse Gaussian transformation. Significance levels were set at P < 0.05 and adjusted using the FDR method for multiple comparisons.
Mediation analysis. To assess whether the effect of a SNP on alcohol consumption is mediated through a brain region, we performed a single-level mediation analysis on the basis of a standard three-variable path model (SNP-brain region-alcohol consumption) with corrected and accelerated percentile bootstrapping 10,000 times to calculate the significance of the mediation effect. We considered the grey-matter volume of brain regions that had a significant association on alcohol consumption to be a mediator variable. We calculated the significance of path a, path b and ab mediation (SNP-brain region-alcohol consumption) using a multilevel mediation and moderation (M3) toolbox 81, 82 . To exclude the possibility of an inverse causal pathway, we performed further analyses in non-drinkers from the UKB (n = 589)-performing 10,000 random permutations for associations between rs13107325 and both left and right putamen. Association analyses. To test associations between cardiac MRI parameters and alcohol-consumption-related SNPs, we carried out a regression of LVM, LVEDV, LVEF, RVEDV and RVEF onto each of the 46 SNPs adjusting for age, sex, height, weight, hypertension (defined as systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg or under antihypertensive treatment), diabetes and smoking history on n = 10,706 participants. Significance levels were set at P < 0.05 and adjusted using the FDR method for multiple comparisons.
Liver imaging. Liver MRI acquisition and preprocessing. Details of the liver image acquisition protocol have been reported previously 85 . In brief, all participants were scanned in a Siemens MAGNETOM Aera 1.5 T MRI scanner (Siemens Healthineers) using a 6-min dual-echo Dixon Vibe protocol, providing a waterand-fat-separated volumetric dataset for fat and muscle covering neck to knees. For the quantification of the liver proton density fat fraction (PDFF), an additional single multi-echo gradient slice was acquired from the liver. Liver images were analysed by computing specific regions of interest for water, fat and T2* using a magnitude-based chemical shift technique with a six-peak lipid model, correcting for T1 and T2*.
Association analyses. We performed association analyses between 46 SNPs related to alcohol consumption and liver PDFF (%), from 8,479 samples, using a linear regression model adjusted for age, age 2 , sex, type 2 diabetes, body mass index, genotyping chip and the first three principal components. Liver PDDF was initially transformed using a rank-based inverse transformation. Significance levels were set at P < 0.05, adjusted using the FDR method for multiple comparisons. , BL 29928. For behavioural experiments, crosses were set up such that experimental and control flies were sibling progeny from a cross, and both were therefore in the same hybrid genetic background (w Berlin/unknown). Flies aged 1-5 d of adult age were collected and after 2 d were exposed to 100/50 (flowrates) ethanol/air vapour in the booz-o-mat, and their loss of righting was determined by slight tapping as described previously 86 . For tolerance, flies were put back onto regular food after an initial 30 min exposure and were then re-exposed to the same vapour 4 h later. Note that tolerance is not connected to initial sensitivity, and flies naively sensitive to ethanol-induced sedation can have a no-tolerance phenotype or a reduced-tolerance phenotype. Flies overexpressing hZIP8 (and their sibling controls) were placed at 28 °C for 2 d to increase the expression levels of the transgene, as we did not detect a phenotype when they were kept at 25 °C (data not shown). Data from experimental and control flies were compared using two-sided Student's t-tests. Data were normally distributed according to ShapiroWilk testing with Bonferroni adjustment for each of the three experiments.
Effects on other traits and diseases. We queried SNPs against GWAS results included in PhenoScanner (http://www.phenoscanner.medschl.cam.ac.uk) to investigate cross-trait effects, and we extracted all association results with genomewide significance at P < 5 × 10 −8 for all of the SNPs in high LD (r 2 ≥ 0.8) with the 46 sentinel new SNPs to highlight the loci with strongest evidence of association with other traits. At the gene level, we performed over-representation enrichment analysis using WebGestalt 41 on the nearest genes to all alcohol-consumptionassociated loci.
The genetic correlations between alcohol consumption and 235 other traits and diseases were obtained using the online software LD Hub. LD Hub is a centralized database of summary-level GWAS results and a web interface for LDSR analysis.
To estimate the potential causal effect of variants related to alcohol consumption on schizophrenia, we performed a Mendelian randomization analysis using publicly available GWAS data on schizophrenia and the Mendelian randomization package in R. The effect was estimated using the inverse-variance weighted method. Pleiotropy was tested by applying the MR-Egger regression method and heterogeneity statistics were obtained. The random-effects inversevariance method was applied in the presence of heterogeneity 87 .
GRSs and percentage of variance explained. We calculated an unbiased weighted GRS in 14,004 unrelated participants from the Airwave cohort-an independent cohort with high-quality HRC-imputed genetic data 33 . All previously reported and new variants were used for the construction of the GRS. We weighted the alcohol-consumption-increasing alleles by the β coefficients of the meta-analysis. We assessed the association of the GRS with alcohol intake and calculated the alcohol consumption levels for individuals in the top versus the bottom quintiles of the distribution. To calculate the percentage variance of alcohol consumption explained by genetic variants, we generated the residuals from a regression of alcohol consumption in the Airwave cohort. We then fit a second linear model for the trait residuals with all new and known variants plus the top ten principal components and estimated the percentage variance of the dependent variable explained by the variants.
Statistical analysis. All inferential statistics for the analyses described above are provided in the text or in tables and figures. All performed tests were two-sided.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The UKB GWAS data can be assessed from the UKB data repository (https:// biota.osc.ox.ac.uk/). The genetic and phenotypic UKB data are available through application to the UKB (https://www.ukbiobank.ac.uk). Summary GWAS data can be assessed by request to the corresponding authors and are available at LDHub (http://ldsc.broadinstitute.org/ldhub/). The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
Open source software was used for this project including BOLT LLM v2.3.2, R v3.5.3, PLINK v1.9, Mango v4.1, GCTA v1.92. We also used IPA for pathway analysis.
Data analysis
For the UKB GWAS analysis, BOLT-LMM software v2.3 was used for running an association analysis using linear mixed modelling; then METAL software was used for all meta-analyses with a fixed effects inverse variance weighted meta-analysis approach. We used R software for any general statistical analyses, for secondary analyses (e.g. variance explained analyses, risk score analyses) and for producing plots in the figures. We used PLINK software for LD calculations of variants. For the bioinformatics analyses, specific software was used for each different analysis. Each method and the software used is described in the Online Methods, For example, IPA was used for the over-representation enrichment analysis etc.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
The UKB GWAS data can be assessed from the UK Biobank data repository (http://biota.osc.ox.ac.uk/). The genetic and phenotypic UKB data are available upon application to the UK Biobank (https://www.ukbiobank.ac.uk). Summary GWAS data data can be assessed by request to the corresponding authors and will be available via LDHub (http://ldsc.broadinstitute.org/ldhub/).
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Sample size
From the ~500,000 UKB participant available, we analyzed 404,731 subjects which passed quality control (QC) of the genetic data, were of European ancestry, and met our phenotypic data QC requirements for availability.
To maximize sample size in the discovery, we recruited an additional 76,111 samples of European descent from 25 cohorts participating in the AlcGen and the CHARGE+ consortia reaching a total discovery sample size of N=480,842.
Data exclusions Within UK Biobank, we excluded samples according to both genetic data quality control (QC) and phenotypic data QC. From genetic data QC, we excluded 968 subjects listed as QC outliers for heterozygosity or missingness within the centrally provided UK Biobank sample QC files, and 378 individuals with sex discordance between the phenotypic and genetically inferred sex. We also restricted to subjects of European ancestry, according to both self-reported ethnicity status and ancestry clustering using PCA data. For phenotypic QC, we excluded any subjects defined as long-time non-drinkers. Participants with with daily alcohol consumption >500 grams were excluded as outliers. We also excluded participants with missing covariates. Similar sample QC was performed at study level within each of the AlcGen and CHARGE+ consortia.
